Efficacy and Safety of neoadjuvant tislelizumab plus chemotherapy for the Treatment of non-small cell lung cancer: A Single-Arm Meta-Analysis Among Chinese Patients

crossref(2024)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要